Logo image
Multidrug resistance in fungi
Journal article   Open access   Peer reviewed

Multidrug resistance in fungi

Kailash Gulshan and W Scott Moye-Rowley
Eukaryotic cell, Vol.6(11), pp.1933-1942
11/2007
DOI: 10.1128/EC.00254-07
PMCID: PMC2168405
PMID: 17873085
url
https://doi.org/10.1128/EC.00254-07View
Published (Version of record) Open Access

Abstract

Multidrug resistance is a problem in chemotherapy in situations ranging from bacterial infections to cancer. Fungal drug resistance is an especially acute issue due to the limited number of antifungal compounds (60). Understanding the regulation and function of multidrug resistance pathways in fungi is still very much a work in progress, but its importance continues to grow with the increasing number of immunocompromised patients worldwide and their increasing reliance on chemotherapy to control fungal infections (see references 84 and 118 for recent reviews). Much of our current understanding of the molecular basis of fungal multidrug resistance springs from work in the typically nonpathogenic yeast S. cerevisiae. However, rapid advances in the experimental tractability of pathogenic fungi such as the Candida and Aspergillus species will bring the pathways in these clinically important organisms into focus. This is an important goal since the systems used for drug resistance in these pathogens share some similarity with those in S. cerevisiae but have important differences that can only be uncovered in the native organism. Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Drug Resistance, Multiple, Fungal Fungi - genetics Fungi - metabolism Gene Expression Regulation, Fungal Homeostasis Membrane Transport Proteins - metabolism Sphingolipids - metabolism

Details

Metrics

Logo image